Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Tumor Cells
100%
Cell Therapy
100%
Therapy Response
100%
Cell Progression
100%
Cell Division
100%
Triple-negative Breast Cancer
72%
Programmed Death-ligand 1 (PD-L1)
50%
Mitosis
33%
Programmed Cell Death Protein 1 (PD-1)
22%
In Cancer
22%
Chromosome Segregation
16%
Nuclear Function
13%
Cohesin
13%
Breast Cancer Subtypes
13%
Breast Cancer Cell Proliferation
11%
Breast Cancer Proliferation
11%
High Risk
11%
Effective Combination
11%
Aggressive Subtypes
11%
Neoadjuvant Chemotherapy
11%
Therapeutic Applications
11%
Successful Completion
11%
Cell Cycle Regulation
11%
Immune System
11%
Conventional Chemotherapy
11%
Knockdown
11%
Cycle Stability
11%
Protein Complex
11%
Cohesion
11%
Genome Stability
11%
Combination Therapy
11%
Antitumor Activity
11%
Triple-negative Breast Cancer Cells
11%
Tumor Response
11%
Surgical Resection
11%
Normal Breast Tissue
11%
Therapeutic Antibody
11%
Chemoradiotherapy
11%
Intracellular Activity
11%
Chromosomal Stability
11%
Novel Treatments
11%
Breast Cancer Progression
11%
Cancer Pathogenesis
11%
Breast Cancer Patients
11%
T Cell Activation
11%
Overall Impact
11%
Estrogen Receptor/progesterone Receptor
11%
Specific Aims
11%
Tumor Immunity
11%
Tumor Growth
11%
Radiotherapy
11%
Targeted Therapy
11%
Cancer Therapy
11%
Negative Breast Cancer
11%
Host Immune Response
11%
Cell Proliferation
8%
GRB2
8%
Triple Negative
8%
Breast
8%
Breast Cancer
8%
Immunology and Microbiology
Tumor Cell
100%
Cell Division
100%
Cell Cycle
60%
Programmed Death 1 Ligand 1
50%
Mitosis
45%
Cell Proliferation
30%
Immune System
17%
Chromosome Segregation
17%
Chromosome
15%
Breast Tissue
15%
Protein Complex
15%
T Cell Activation
15%
Antineoplastic Activity
15%
Cancer Cell
15%
Genomic Instability
15%
Programmed Death 1 Receptor
15%
Therapeutic Antibodies
15%
Chromosomal Instability
15%
Growth Factor
12%